Stock DNLI DENALI THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Denali Therapeutics Inc.

Equities

DNLI

US24823R1059

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-15 EDT 		5-day change 1st Jan Change
20.86 USD +5.62% Intraday chart for Denali Therapeutics Inc. +10.37% -2.80%
05-08 Stifel Adjusts Price Target on Denali Therapeutics to $22 From $26, Maintains Hold Rating MT
05-08 Wedbush Adjusts Denali Therapeutics' Price Target to $30 From $31, Keeps Outperform Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
DENALI THERAPEUTICS INC. Stock Denali Therapeutics Inc.
 2.97B -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 113B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
ARGENX SE Stock argenx SE
 22.27B -
BIONTECH SE Stock BioNTech SE
 22.22B -
GENMAB A/S Stock Genmab A/S
 19.43B
  1. Stock Market
  2. Equities
  3. DNLI Stock
  4. Charts Denali Therapeutics Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW